Shandong Xinhua Pharmaceutical Company Limited (HKG:0719)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
6.99
-0.01 (-0.14%)
At close: Feb 13, 2026

HKG:0719 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
Operating Revenue
8,3528,3247,9567,2956,3605,949
Other Revenue
142.44142.44144.78207.82200.5456.85
8,4958,4668,1017,5036,5606,006
Revenue Growth (YoY)
1.89%4.51%7.97%14.37%9.23%7.13%
Cost of Revenue
6,7956,4815,7795,5154,8244,244
Gross Profit
1,6991,9852,3211,9881,7361,762
Selling, General & Admin
817.341,0171,2871,106929.12943.96
Research & Development
386.62413.18419.24345.66341.37298.35
Other Operating Expenses
47.4935.8892.1865.3159.2760.28
Operating Expenses
1,2611,4751,8091,5221,3321,303
Operating Income
438.55510.63512.15465.87403.67458.77
Interest Expense
-40.38-39.74-41.15-49.71-53.1-59.76
Interest & Investment Income
14.7720.9621.8818.8316.7911.58
Currency Exchange Gain (Loss)
19.0919.0915.4210.53-4.18-24.78
Other Non Operating Income (Expenses)
-4.27-3.41-2.72-3.38-2.45-4.46
EBT Excluding Unusual Items
427.76507.53505.59442.15360.72381.35
Gain (Loss) on Sale of Assets
1.41.428.735.542.072.49
Asset Writedown
-7.1-5.12-10.29-2.61-1.88-4.43
Other Unusual Items
24.6729.8228.6526.760.3232.23
Pretax Income
446.73533.65532.69471.77421.23411.64
Income Tax Expense
48.5646.9426.5845.6659.1664.52
Earnings From Continuing Operations
398.17486.71506.11426.11362.07347.11
Minority Interest in Earnings
-16.01-16.69-9.59-15.05-13.53-22.25
Net Income
382.16470.02496.51411.06348.55324.86
Net Income to Common
382.16470.02496.51411.06348.55324.86
Net Income Growth
-14.81%-5.33%20.79%17.94%7.29%8.30%
Shares Outstanding (Basic)
685682674661627622
Shares Outstanding (Diluted)
691688692671627627
Shares Change (YoY)
-0.13%-0.54%3.20%6.93%-0.02%0.86%
EPS (Basic)
0.560.690.740.620.560.52
EPS (Diluted)
0.550.680.720.610.560.52
EPS Growth
-15.48%-5.56%18.03%9.75%6.89%8.33%
Free Cash Flow
268.97155.19-59.85513.489.89140
Free Cash Flow Per Share
0.390.23-0.090.770.020.22
Dividend Per Share
0.2500.2750.2500.2000.1500.150
Dividend Growth
-9.09%10.00%25.00%33.33%-25.00%
Gross Margin
20.01%23.45%28.66%26.50%26.46%29.33%
Operating Margin
5.16%6.03%6.32%6.21%6.15%7.64%
Profit Margin
4.50%5.55%6.13%5.48%5.31%5.41%
Free Cash Flow Margin
3.17%1.83%-0.74%6.84%0.15%2.33%
EBITDA
995.961,0491,026952.48840.2842.97
EBITDA Margin
11.72%12.40%12.67%12.70%12.81%14.04%
D&A For EBITDA
557.41538.84514.09486.61436.53384.2
EBIT
438.55510.63512.15465.87403.67458.77
EBIT Margin
5.16%6.03%6.32%6.21%6.15%7.64%
Effective Tax Rate
10.87%8.80%4.99%9.68%14.04%15.68%
Revenue as Reported
28.45--7,503-6,006
Advertising Expenses
-7.468.958.1811.3312.84
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.